With the development of deep sequencing and bioinformatics technology, a large number of products produced by abnormal RNA splicing, such as chimeric RNA and chimeric/fusion proteins, have been discovered. Natural chimeric/fusion genes are new genes formed by natural fusion of two or more independent genes. Chimeric RNAs can be transcribed by natural chimeric genes, and can also be formed by cis-splicing or trans-splicing of two or more precursor mRNAs. Unlike fusion genes, the production of chimeric RNAs does not involve changes in the DNA level of chromosomes. At first, chimeric RNAs were found as tumor markers. With the deepening of research, researchers also found a large number of chimeric RNAs in normal tissues. From the perspective of biological function, chimeric RNAs can play a biological role in regulating the expression of corresponding maternal genes, translating into chimeric proteins, and forming long non-coding RNAs. The objective of the present study focused on the frontiers of chimeric RNA and reviewed its role in health and tumor study to reveal research progress of chimeric RNA and health and provide a new sight of relative disease treatment. The main conclusion of this review is that chimeric RNA may serve as a biomarker for specific tumor diagnose and treatment while its role in normal physiology needs to be revealed.
Li, Y.X., Zhang, T.T. and Ma, L. (2018) Structural Characteristics of Natural Chimeric Genes and Their Implications for Gene Design. Genetic, 40, 135-144.
Nowell, P.C. (1962) The Minute Chromosome (Phl) in Chronic Granulocytic Leukemia. Blut, 8, 65-66. https://doi.org/10.1007/BF01630378
Rowley, J.D. (1973) Letter: A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia Identified by Quinacrine Fluorescence and Giemsa Staining. Nature, 243, 290-293. https://doi.org/10.1038/243290a0
Romana, S.P., Mauchauffe, M., Le Coniat, M., et al. (1995) The t(12;21) of Acute Lymphoblastic Leukemia Results in a tel-AML1 Gene Fusion. Blood, 85, 3662-3670. https://doi.org/10.1182/blood.V85.12.3662.bloodjournal85123662
Nucifora, G., Birn, D.J., Erickson, P., et al. (1993) Detection of DNA Rearrangements in the AML1 and ETO Loci and of an AML1/ETO Fusion mRNA in Patients with t(8;21) Acute Myeloid Leukemia. Blood, 81, 883-888. https://doi.org/10.1182/blood.V81.4.883.bloodjournal814883
Barr, F.G., Galili, N., Holick, J., et al. (1993) Rearrangement of the PAX3 Paired Box Gene in the Paediatric Solid Tumour Alveolar Rhabdomyosarcoma. Nature Genetics, 3, 113-117. https://doi.org/10.1038/ng0293-113
Tomlins, S.A., Rhodes, D.R., Perner, S., et al. (2005) Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer. Science, 310, 644-648. https://doi.org/10.1126/science.1117679
Kannan, K., Coarfa, C., Chao, P.W., et al. (2015) Recurrent BCAM-AKT2 Fusion Gene Leads to a Constitutively Activated AKT2 Fusion Kinase in High-Grade Serous Ovarian Carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 112, E1272-E1277. https://doi.org/10.1073/pnas.1501735112
Kim, D.S., Huh, J.W. and Kim, H.S. (2007) HYBRIDdb: A Database of Hybrid Genes in the Human Genome. BMC Genomics, 8, 128. https://doi.org/10.1186/1471-2164-8-128
Wang, Y., Wu, N., Liu, J., et al. (2015) FusionCancer: A Database of Cancer Fusion Genes Derived from RNA-seq Data. Diagnostic Pathology, 10, 131. https://doi.org/10.1186/s13000-015-0310-4
Prakash, T., Sharma, V.K., Adati, N., et al. (2010) Expression of Conjoined Genes: Another Mechanism for Gene Regulation in Eukaryotes. PLoS ONE, 5, e13284. https://doi.org/10.1371/journal.pone.0013284
Novo, F.J., de Mendibil, I.O. and Vizmanos, J.L. (2007) TICdb: A Collection of Gene-Mapped Translocation Breakpoints in Cancer. BMC Genomics, 8, 33. https://doi.org/10.1186/1471-2164-8-33
Kong, F., Zhu, J., Wu, J., et al. (2011) dbCRID: A Database of Chromosomal Rearrangements in Human Diseases. Nucleic Acids Research, 39, D895-D900. https://doi.org/10.1093/nar/gkq1038
Suhre, K. and Claverie, J.M. (2004) FusionDB: A Database for In-Depth Analysis of Prokaryotic Gene Fusion Events. Nucleic Acids Research, 32, D273-D276. https://doi.org/10.1093/nar/gkh053
Gorohovski, A., Tagore, S., Palande, V., et al. (2017) ChiTaRS-3.1—The Enhanced Chimeric Transcripts and RNA-seq Database Matched with Protein-Protein Interactions. Nucleic Acids Research, 45, D790-D795. https://doi.org/10.1093/nar/gkw1127
Lee, M., Lee, K., Yu, N., et al. (2017) ChimerDB 3.0: An Enhanced Database for Fusion Genes from Cancer Transcriptome and Literature Data Mining. Nucleic Acids Research, 45, D784-D789.
Mitelman, F. (2000) Recurrent Chromosome Aberrations in Cancer. Mutation Research, 462, 247-253. https://doi.org/10.1016/S1383-5742(00)00006-5
Li, Z., Qin, F. and Li, H. (2018) Chimeric RNAs and Their Implications in Cancer. Current Opinion in Genetics and Development, 48, 36-43. https://doi.org/10.1016/j.gde.2017.10.002
Zhu, J. (1995) Analysis of Conditional Genetic Effects and Variance Components in Developmental Genetics. Genetics, 141, 1633-1639. https://doi.org/10.1093/genetics/141.4.1633
Aurias, A., Rimbaut, C., Buffe, D., et al. (1984) Translocation Involving Chromosome 22 in Ewing’s Sarcoma. A Cytogenetic Study of Four Fresh Tumors. Cancer Genetics and Cytogenetics, 12, 21-25. https://doi.org/10.1016/0165-4608(84)90003-7
Quintas-Cardama, A. and Cortes, J. (2009) Molecular Biology of Bcr-abl1-Positive Chronic Myeloid Leukemia. Blood, 113, 1619-1630. https://doi.org/10.1182/blood-2008-03-144790
Qin, F., Shi, X. and Li, H. (2020) Knockdown of Chimeric RNA by RNAi. Methods in Molecular Biology, 2079, 143-154. https://doi.org/10.1007/978-1-4939-9904-0_11
Kannan, K., Wang, L., Wang, J., et al. (2011) Recurrent Chimeric RNAs Enriched in Human Prostate Cancer Identified by Deep Sequencing. Proceedings of the National Academy of Sciences of the United States of America, 108, 9172-9177. https://doi.org/10.1073/pnas.1100489108
Nacu, S., Yuan, W., Kan, Z., et al. (2011) Deep RNA Sequencing Analysis of Read through Gene Fusions in Human Prostate Adenocarcinoma and Reference Samples. BMC Medical Genomics, 4, 11. https://doi.org/10.1186/1755-8794-4-11
Yuan, C., Han, Y., Zellmer, L., et al. (2017) It Is Imperative to Establish a Pellucid Definition of Chimeric RNA and to Clear Up a Lot of Confusion in the Relevant Research. International Journal of Molecular Sciences, 18, 714. https://doi.org/10.3390/ijms18040714
Qin, F., Song, Y., Zhang, Y., et al. (2016) Role of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA. PLoS ONE, 11, e150382. https://doi.org/10.1371/journal.pone.0150382
Rickman, D.S., Pflueger, D., Moss, B., et al. (2009) SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation-Specific Fusion Transcript in Prostate Cancer. Cancer Research, 69, 2734-2738. https://doi.org/10.1158/0008-5472.CAN-08-4926
Kumar-Sinha, C., Kalyana-Sundaram, S. and Chinnaiyan, A.M. (2012) SLC45A3-ELK4 Chimera in Prostate Cancer: Spotlight on cis-Splicing. Cancer Discovery, 2, 582-585. https://doi.org/10.1158/2159-8290.CD-12-0212
Zhang, Y., Gong, M., Yuan, H., et al. (2012) Chimeric Transcript Generated by cis-Splicing of Adjacent Genes Regulates Prostate Cancer Cell Proliferation. Cancer Discovery, 2, 598-607. https://doi.org/10.1158/2159-8290.CD-12-0042
Milhausen, M., Nelson, R.G., Sather, S., et al. (1984) Identification of a Small RNA Containing the Trypanosome Spliced Leader: A Donor of Shared 5’ Sequences of Trypanosomatid mRNAs? Cell, 38, 721-729. https://doi.org/10.1016/0092-8674(84)90267-8
Koller, B., Fromm, H., Galun, E., et al. (1987) Evidence for in Vivo Trans Splicing of pre-mRNAs in Tobacco Chloroplasts. Cell, 48, 111-119. https://doi.org/10.1016/0092-8674(87)90361-8
Kuck, U., Choquet, Y., Schneider, M., et al. (1987) Structural and Transcription Analysis of Two Homologous Genes for the P700 Chlorophyll a-Apoproteins in Chlamydomonas reinhardii: Evidence for in Vivo Trans-Splicing. The EMBO Journal, 6, 2185-2195. https://doi.org/10.1002/j.1460-2075.1987.tb02489.x
Chwalenia, K., Facemire, L. and Li, H. (2017) Chimeric RNAs in Cancer and Normal Physiology. Wiley Interdisciplinary Reviews: RNA, 8, e1427. https://doi.org/10.1002/wrna.1427
Greger, L., Su, J., Rung, J., et al. (2014) Tandem RNA Chimeras Contribute to Transcriptome Diversity in Human Population and Are Associated with Intronic Genetic Variants. PLoS ONE, 9, e104567. https://doi.org/10.1371/journal.pone.0104567
Li, H., Wang, J., Mor, G., et al. (2008) A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells. Science, 321, 1357-1361. https://doi.org/10.1126/science.1156725
Caudevilla, C., Serra, D., Miliar, A., et al. (1998) Natural Trans-Splicing in Carnitine Octanoyltransferase pre-mRNAs in Rat Liver. Proceedings of the National Academy of Sciences of the United States of America, 95, 12185-12190. https://doi.org/10.1073/pnas.95.21.12185
Lei, Q., Li, C., Zuo, Z., et al. (2016) Evolutionary Insights into RNA Trans-Splicing in Vertebrates. Genome Biology and Evolution, 8, 562-577. https://doi.org/10.1093/gbe/evw025
Muddathir, A.M., Kordofani, A.A. and Fadl-Elmula, I.M. (2013) Frequency of BCR-ABL Fusion Transcripts in Sudanese Patients with Chronic Myeloid Leukemia Using Real-Time Reverse Transcription-Polymerase Chain Reaction. Saudi Medical Journal, 34, 29-33.
Soda, M., Choi, Y.L., Enomoto, M., et al. (2007) Identification of the Transforming EML4-ALK Fusion Gene in Non-Small-Cell Lung Cancer. Nature, 448, 561-566. https://doi.org/10.1038/nature05945
Yang, Y.Z., Pan, L.K. and An, G.Y. (2012) Biological Characteristics of EML4-ALK Fusion Gene in Non-Small Cell Lung Cancer and Its Treatment. Cancer, 32, 466-470.
Wang, L.J. and Guo, Q.S. (2014) EML4-ALK Fusion Gene: A New Clinical Target for Advanced Non-Small Cell Lung Cancer. Chin J Lung Dis, No. 1, 108-111.
Guo, Q. and Yu, Y.H. (2014) Expression and Significance of TMPRSS2-ERG Fusion Gene and ERG Protein in Prostate Cancer. Journal of Clinical and Experimental Pathology, No. 10, 1099-1103.
Iyer, M.K., Niknafs, Y.S., Malik, R., et al. (2015) The Landscape of Long Noncoding RNAs in the Human Transcriptome. Nature Genetics, 47, 199-208. https://doi.org/10.1038/ng.3192
Qin, F., Zhang, Y., Liu, J., et al. (2017) SLC45A3-ELK4 Functions as a Long Non-Coding Chimeric RNA. Cancer Letters, 404, 53-61. https://doi.org/10.1016/j.canlet.2017.07.007
Maher, C.A., Kumar-Sinha, C., Cao, X., et al. (2009) Transcriptome Sequencing to Detect Gene Fusions in Cancer. Nature, 458, 97-101. https://doi.org/10.1038/nature07638
Frenkel-Morgenstern, M., Lacroix, V., Ezkurdia, I., et al. (2012) Chimeras Taking Shape: Potential Functions of Proteins Encoded by Chimeric RNA Transcripts. Genome Research, 22, 1231-1242. https://doi.org/10.1101/gr.130062.111
Babiceanu, M., Qin, F., Xie, Z., et al. (2016) Recurrent Chimeric Fusion RNAs in Non-Cancer Tissues and Cells. Nucleic Acids Research, 44, 2859-2872. https://doi.org/10.1093/nar/gkw032
Wong, S. and Witte, O.N. (2004) The BCR-ABL Story: Bench to Bedside and Back. Annual Review of Immunology, 22, 247-306. https://doi.org/10.1146/annurev.immunol.22.012703.104753
Zhang, H., Lin, W., Kannan, K., et al. (2013) Aberrant Chimeric RNA GOLM1-MAK10 Encoding a Secreted Fusion Protein as a Molecular Signature for Human Esophageal Squamous Cell Carcinoma. Oncotarget, 4, 2135-2143. https://doi.org/10.18632/oncotarget.1465
Tang, Y. (2019) Analysis of Chimeric RNA in Infant Brain Tissue and Function Study of DUS4L-BCAP29. Zhengzhou University, Zhengzhou.
Ke, X.R., Xiong, X., Lin, Y.S., et al. (2019) Research and Transformation of Exosome Tumor Vaccine. Wuhan, 1.
Shtivelman, E., Lifshitz, B., Gale, R.P., et al. (1985) Fused Transcript of abl and bcr Genes in Chronic Myelogenous Leukaemia. Nature, 315, 550-554. https://doi.org/10.1038/315550a0
Sattler, M. and Griffin, J.D. (2001) Mechanisms of Transformation by the BCR/ABL Oncogene. International Journal of Hematology, 73, 278-291. https://doi.org/10.1007/BF02981952
Mitelman, F., Johansson, B. and Mertens, F. (2007) The Impact of Translocations and Gene Fusions on Cancer Causation. Nature Reviews Cancer, 7, 233-245. https://doi.org/10.1038/nrc2091
Wu, P., Yang, S., Singh, S., et al. (2018) The Landscape and Implications of Chimeric RNAs in Cervical Cancer. EBioMedicine, 37, 158-167. https://doi.org/10.1016/j.ebiom.2018.10.059
Li, B.J., Zhu, Z.H., Wang, J.Y., et al. (2014) Expression Correlation of Ki67 to P53, VEGF, and C-erbB-2 Genes in Breast Cancer and Their Clinical Significances. Chinese Journal of Cancer, 23, 1176-1179.
Ma, L. and Zhang, T.T. (2018) Application of Chimeric Gene Examples to Expand the Teaching of Genetic Chromosome Aberrations. Genetic, 40, 1129-1136.
Elfman, J. and Li, H. (2018) Chimeric RNA in Cancer and Stem Cell Differentiation. Stem Cells International, 2018, Article ID: 3178789. https://doi.org/10.1155/2018/3178789
Li, H., Wang, J., Ma, X., et al. (2009) Gene Fusions and RNA Trans-Splicing in Normal and Neoplastic Human Cells. Cell Cycle, 8, 218-222. https://doi.org/10.4161/cc.8.2.7358
Yuan, H., Qin, F., Movassagh, M., et al. (2013) A Chimeric RNA Characteristic of Rhabdomyosarcoma in Normal Myogenesis Process. Cancer Discovery, 3, 1394-1403. https://doi.org/10.1158/2159-8290.CD-13-0186
Tang, Y., Qin, F., Liu, A., et al. (2017) Recurrent Fusion RNA DUS4L-BCAP29 in Non-Cancer Human Tissues and Cells. Oncotarget, 8, 31415-31423. https://doi.org/10.18632/oncotarget.16329
Tang, Y., Ma, S., Wang, X., et al. (2019) Identification of Chimeric RNAs in Human Infant Brains and Their Implications in Neural Differentiation. The International Journal of Biochemistry & Cell Biology, 111, 19-26. https://doi.org/10.1016/j.biocel.2019.03.012
Rickman, D.S., Beltran, H., Demichelis, F., et al. (2017) Biology and Evolution of Poorly Differentiated Neuroendocrine Tumors. Nature Medicine, 23, 1-10. https://doi.org/10.1038/nm.4341
van der Kouwe, E. and Staber, P.B. (2019) RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia. International Journal of Molecular Sciences, 20, 350. https://doi.org/10.3390/ijms20020350
Anetta, P., Anna, P., Salam, A.A., et al. (2019) RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction. Cell Reports, 28, 3022-3031.e1-e7. https://doi.org/10.1016/j.celrep.2019.08.040